Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “GLIOBLASTOMA MULTIFORME”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT07386002
What this trial is testing

The GLIOMAX Study: MT027 Allogeneic CAR-T for Recurrent Glioma

Who this might be right for
Glioblastoma IDH (Isocitrate Dehydrogenase) Wildtype
T-MAXIMUM Pharmaceutical Inc 40
Testing effectiveness (Phase 2)Study completedNCT01071837
What this trial is testing

APG101 in Glioblastoma

Who this might be right for
Glioblastoma Multiforme
Apogenix GmbH 84
Testing effectiveness (Phase 2)Study completedNCT03665545
What this trial is testing

Pembrolizumab in Association With the IMA950/Poly-ICLC for Relapsing Glioblastoma

Who this might be right for
Glioblastoma MultiformeGlioblastoma, AdultGlioma of Brain+1 more
University Hospital, Geneva 18
Testing effectiveness (Phase 2)Study completedNCT01817751
What this trial is testing

Sorafenib, Valproic Acid, and Sildenafil in Treating Patients With Recurrent High-Grade Glioma

Who this might be right for
GlioblastomaRecurrent Adult Brain NeoplasmMalignant Glioma+1 more
Virginia Commonwealth University 47
Testing effectiveness (Phase 2)UnknownNCT01083719
What this trial is testing

A Comparison of FDG-PET Versus MRI Based Target Volume Delineation in Glioblastoma and the Role of FDG-PET/CT in the Alteration of MRI Based Target Volumes.

Who this might be right for
Glioblastoma
Medanta Institute of Clinical Research 15
Early research (Phase 1)Study completedNCT07635173
What this trial is testing

SM-1 Combined With Temozolomide in Subjects With Refractory or Recurrent High-Grade Gliomas

Who this might be right for
GliomaGlioblastomas (GBM)High Grade Gliomas
Shenzhen Zhenxing Medical Technology Co., Ltd 35
Early research (Phase 1)Study completedNCT01576666
What this trial is testing

Phase Ib, Dose Escalation Study of Oral LDE225 in Combination With BKM120 in Patients With Advanced Solid Tumors

Who this might be right for
Dose EscalationSafetyPreliminary Efficacy+9 more
Novartis Pharmaceuticals 120
Not applicableEnded earlyNCT00589095
What this trial is testing

Early Detection of Glioblastoma Multiforme (GBM) Treatment Responses Using Multiple Magnetic Resonance Modalities

Who this might be right for
Glioblastoma Multiforme
Yale University 5
Very early researchLooking for participantsNCT07268053
What this trial is testing

A Phase 0/1 Clinical Trial With an Expansion Phase of GSK5764227, a B7-H3-Targeted Antibody-Drug Conjugate (ADC), in Patients With Recurrent Grade 4 Glioma and Patients With Brain Metastases

Who this might be right for
Glioblastoma (GBM)Brain Metastasases
Nader Sanai 15
Testing effectiveness (Phase 2)WithdrawnNCT01115036
What this trial is testing

A Panobinostat Presurgery

Who this might be right for
Recurrent Glioblastoma
Duke University
Not applicableStudy completedNCT02431572
What this trial is testing

A Pilot Study to Evaluate PBR PET in Brain Tumor Patients Treated With Chemoradiation or Immunotherapy

Who this might be right for
Intracranial TumorsGlioblastomaMelanoma
Massachusetts General Hospital 11
Testing effectiveness (Phase 2)Study completedNCT00870181
What this trial is testing

ADV-TK Improves Outcome of Recurrent High-Grade Glioma

Who this might be right for
Malignant Glioma of BrainGlioblastoma
Huazhong University of Science and Technology 47
Testing effectiveness (Phase 2)Study completedNCT04238819
What this trial is testing

Abemaciclib (LY2835219) in Combination With Other Anti-Cancer Treatments in Children and Young Adult Participants With Solid Tumors, Including Neuroblastoma

Who this might be right for
Relapsed Solid TumorRefractory Solid Tumor
Eli Lilly and Company 47
Early research (Phase 1)Ended earlyNCT03170141
What this trial is testing

Immunogene-modified T (IgT) Cells Against Glioblastoma Multiforme

Who this might be right for
Glioblastoma Multiforme of BrainBrain Cancer
Shenzhen Geno-Immune Medical Institute 30
Not applicableStudy completedNCT02441322
What this trial is testing

Evaluating Therapeutic Response to Novo-TTF

Who this might be right for
Glioblastoma Multiforme
Abramson Cancer Center at Penn Medicine 30
Not applicableActive Not RecruitingNCT06054529
What this trial is testing

Spatiotemporal Dimensions of Metabolism in Autochthonous Tumors of GBM Patients

Who this might be right for
Glioblastoma Multiforme
AdventHealth Translational Research Institute 2
Not applicableActive Not RecruitingNCT03244995
What this trial is testing

Mind-Body Intervention in Glioma Couples

Who this might be right for
GlioblastomaLow Grade GliomaMalignant Glioma+3 more
M.D. Anderson Cancer Center 74
Testing effectiveness (Phase 2)Ended earlyNCT02663271
What this trial is testing

TTFields and Pulsed Bevacizumab for Recurrent Glioblastoma

Who this might be right for
Glioblastoma MultiformeGlioblastomaMalignant Glioma+1 more
University of Florida 10
Not applicableStudy completedNCT01165671
What this trial is testing

Carbon Ion Radiotherapy for Primary Glioblastoma

Who this might be right for
Primary Glioblastoma
University Hospital Heidelberg 100
Not applicableUnknownNCT05539339
What this trial is testing

Personalized Trial in ctDNA-level-relapse Glioblastoma

Who this might be right for
Glioblastoma
Henan Provincial People's Hospital 20
Next Page